Korbecki, J.; Bosiacki, M.; Pilarczyk, M.; Kot, M.; Defort, P.; Walaszek, I.; Chlubek, D.; Baranowska-Bosiacka, I.
The CXCL1-CXCR2 Axis as a Component of Therapy Resistance, a Source of Side Effects in Cancer Treatment, and a Therapeutic Target. Cancers 2025, 17, 1674.
https://doi.org/10.3390/cancers17101674
AMA Style
Korbecki J, Bosiacki M, Pilarczyk M, Kot M, Defort P, Walaszek I, Chlubek D, Baranowska-Bosiacka I.
The CXCL1-CXCR2 Axis as a Component of Therapy Resistance, a Source of Side Effects in Cancer Treatment, and a Therapeutic Target. Cancers. 2025; 17(10):1674.
https://doi.org/10.3390/cancers17101674
Chicago/Turabian Style
Korbecki, Jan, Mateusz Bosiacki, Maciej Pilarczyk, Marcin Kot, Piotr Defort, Ireneusz Walaszek, Dariusz Chlubek, and Irena Baranowska-Bosiacka.
2025. "The CXCL1-CXCR2 Axis as a Component of Therapy Resistance, a Source of Side Effects in Cancer Treatment, and a Therapeutic Target" Cancers 17, no. 10: 1674.
https://doi.org/10.3390/cancers17101674
APA Style
Korbecki, J., Bosiacki, M., Pilarczyk, M., Kot, M., Defort, P., Walaszek, I., Chlubek, D., & Baranowska-Bosiacka, I.
(2025). The CXCL1-CXCR2 Axis as a Component of Therapy Resistance, a Source of Side Effects in Cancer Treatment, and a Therapeutic Target. Cancers, 17(10), 1674.
https://doi.org/10.3390/cancers17101674